Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...
Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...
New research to be presented at next week's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) highlights the risk of new immune-evasive SARS-CoV-2 variants emerging in ...
Announcing a new article publication for Zoonoses journal. Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in more than 30 mammalian ...
If you’ve been spending any time around virologists (or, really, anywhere) over these last few pandemic-stricken years, you may be sick of hearing about a particular viral protein called spike. For ...
VRBPAC is evaluating an XFG-targeted composition for 2026–2027 vaccines, based on CDC variant prevalence estimates that are more than a month old. FDA briefing materials emphasize eroding sequencing ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The virologist had recently started an independent group at the University of Tokyo ...
Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results